-
Improving maternity care with digitalised care plans
FRISQ and Aleris have together with Aleris-owned BB Stockholm and Ultragyn entered into a collaboration to implement a digital, interactive care plan in order to strengthen the collaboration between the prospective parent couple, the midwife clinic and the delivery unit. The ambition of the project is to streamline resource utilization through modernized working methods and …
More -
Update regarding offer on FRISQ’s operating subsidiaries
As previously announced, The Board of Directors (“Board”) of FRISQ Holding AB (publ) ("FRISQ" or "the Company") has received a non-binding offer for the Company's operating subsidiaries FRISQ AB, FRISQ UK LTD and FRISQ USA Holding Inc (together the "Subsidiaries") for a total purchase price of approximately SEK 106 million. The offer has been submitted …
More -
FRISQ expands its collaboration with Capio through a new agreement with Capio Orthopedics
After a 12-month pilot project, Capio Orthopedics now signs a three-year agreement with FRISQ. The purpose of the agreement is to introduce the digital process support FRISQ Care in all Capio Orthopedics units in accordance with the offered licensing and implementation costs. Capio, one of Europe's leading healthcare companies, has for 12 months used and …
More -
FRISQ has received an offer regarding a divestment of its operating subsidiaries
Insider information: The Board of Directors (“Board”) of FRISQ Holding AB (publ) ("FRISQ" or "the Company") has received an offer for the Company's operating subsidiaries FRISQ AB, FRISQ UK LTD and FRISQ USA Holding Inc (together the "Subsidiaries") for a total purchase price of approximately SEK 106 million. The non-binding offer has been submitted by …
More -
FRISQ signs a credit facility of SEK 15 million
FRISQ Holding AB has today reached an agreement regarding a credit facility with Gryningskust Holding AB and Crafoord Capital Partners AB. The credit facility amounts to SEK 15 million. As communicated in the interim report for the third quarter, FRISQ works to ensure long-term financing and evaluates several alternatives for structural changes and evaluates a …
More -
FRISQ in collaboration with UCB and Amgen to facilitate the implementation of care plans for Osteoporosis patients
FRISQ has entered into an agreement with biotechnology companies UCB and Amgen, to collaborate with selected clinics to design comprehensive, digitalized care plans for patients suffering from osteoporosis. The project will be financed by UCB Pharma Sweden. The order value for FRISQ is approximately SEK 0.5 million, excluding any additional orders for implementation and license …
More